EUCTR2019-004303-12-DK进行中（未招募）1 期
The effects of SGLT2-inhibition in patients with type 2 diabetes and preserved kidney function on renal hemodynamics, kidney function and vasoactive hormones
niversity Clinic of Nephrology and Hypertension, Regional Hospital Holstebro0 个研究点目标入组 20 人开始时间: 2020年6月23日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Over 18 years of age
- •eGFR > 60 ml/min
- •Type 2 diabetes diagnosed at least 1 year before inclusion and in stable Medical antidiabetic treatment for at least 3 months
- •HbA1c 48 – 70 mmol/mol
- •Fertile women are to use safe contraception
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 10
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 10
排除标准
- •Type 1 diabetes
- •Alcohol or substance abuse
- •Pregnancy or breastfeeding
- •Anamnestic or clinical signs of heart- or liver failure
- •Active cancers, aside from skin cancers (spinocellular or basocellular carcinomas)
- •Allergies or unacceptable side effects to the experimental treatment or background treatment
- •If investigator finds the participant unfit to complete the trial
研究者
相似试验
招募中
4 期
Effects of SGLT-2 inhibitors for the patients with non-alcoholic fatty liver disease (NAFLD) complicated with type 2 diabetes mellitus.on-alcoholic fatty liver disease (NAFLD) complicated with type 2 diabetes mellitus.JPRN-UMIN000018913Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine50
已完成
不适用
Effects of treatment with SGLT2 inhibitor on the initiation of continuous positive airway pressure therapy in type 2 diabetic patients with obstructive sleep apnea syndromeType 2 diabetesJPRN-UMIN000045226Akishima Clinic16
尚未招募
2 期
Mechanisms of action of SGLT2 inhibitors in patients with heart failure with reduced ejection fraction (HFrEF)Heart Failure with Reduced Ejection fractionCardiovascular - Other cardiovascular diseasesACTRN12621000187842The Alfred Hospital36
已完成
不适用
The inhibitory effects of the SGLT2 inhibitor for progression of diabetic nephropathy, in the patients with type 2 diabetes in Japan.diabetic nephropathy in type 2 diabetes mellitusJPRN-UMIN000016754Saitama Medical Center, Saitama Medical University50
尚未招募
Unknown
Influence of SGLT2 inhibitors on the efficiency of peritoneal dialysisChronic kidney disease under peritoneal dialysisJPRN-UMIN000049848International University of Health and Welfare10